Olivier LAUREAU, President of Schweria Group: We will collaborate on innovation and work together to create value for the well-being of patients

Why does an international pharmaceutical group managed by a non-profit foundation consider China as a key market? In this issue of Global Business Leaders, we will interview Mr. Olivier LAUREAU, President of Schwyzer Group. He will deeply interpret how Schwyzer focuses on the fields of refractory tumors and neuroscience, and reveal the strategic significance of the Chinese market in its global innovation map. Stay tuned!